Results 81 to 90 of about 3,321,798 (216)

MRI Responsive Contrast Agents: Towards Sensing and Imaging of Neurotransmitters [PDF]

open access: green, 2012
Fatima Oukhatar   +3 more
openalex  

QSAR analysis and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents

open access: yesHeliyon, 2019
The norepinephrine transporter (NET) is a Na+/Cl− coupled neurotransmitter transporter responsible for reuptake of released norepinephrine (NE) into nerve terminals in the brain, a key therapeutic used in the treatment of psychiatric disorders.
Sabitu Babatunde Olasupo   +3 more
doaj  

RetS senses neurotransmitter norepinephrine and adrenergic agents to regulate Pseudomonas aeruginosa virulence [PDF]

open access: green
Ying Zhou   +11 more
openalex   +1 more source

Glutamatergic agents for OCD and related disorders

open access: yesCurrent Treatment Options in Psychiatry, 2015
C. Pittenger
semanticscholar   +1 more source

Novel glutamatergic drugs for the treatment of mood disorders

open access: yesNeuropsychiatric Disease and Treatment, 2013
Kyle AB Lapidus, Laili Soleimani, James W MurroughMood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USAAbstract: Mood disorders are common and debilitating, resulting in a significant ...
Murrough JW, Lapidus KAB, Soleimani L
doaj  

Novel Agents for the Treatment of Type 2 Diabetes

open access: yesDiabetes Spectrum, 2014
R. DeFronzo   +3 more
semanticscholar   +1 more source

From neurotoxicity to neuroprotection: Rethinking GABA<sub>A</sub>R-targeting anesthetics. [PDF]

open access: yesCell Biol Toxicol
Li Y   +10 more
europepmc   +1 more source

A comparative exploration of monoamine neurotransmitter transport disorders: mechanisms, clinical manifestations, and therapeutic approaches. [PDF]

open access: yesJ Med Life
Al Sari RR   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy